What it captures
Anti-dumping (AD), countervailing (CVD) and safeguard duty investigations and orders that are procedurally standard trade-defence actions — a domestic producer petitions a national trade-remedy authority (Korea's KTC/MOEF, the EU Commission's DG Trade, Turkey's Ministry of Trade, South Africa's ITAC, Mexico's SE/UPCI, the GCC's TSAIP, UAE's MOET, etc.) alleging injury from dumped or subsidised imports of a specific product from a specific exporting country, and the authority investigates, imposes a provisional duty, and (often months later) a definitive duty.
These cases are numerous, individually narrow in scope (one product, one or two exporting countries), and not obviously part of any single strategic-competition narrative. They are distinct from AD/CVD cases that are clearly part of a broader thematic arc already tracked elsewhere in the register (e.g. China-targeted AD/CVD waves tied to overcapacity diplomacy, or AD cases explicitly framed by the issuing authority as a response to US Section 232 tariff-driven trade redirection) — those stay in their more specific theme.
Why it matters
The aggregate volume and geographic spread of conventional trade-remedy activity is itself a signal: it tracks the background rate of import-injury protectionism across the trading system, independent of the headline industrial-policy and sanctions architectures tracked elsewhere. Grouping these standalone cases here avoids either leaving them unthemed or diluting the more precisely scoped strategic-competition themes with cases that don't actually belong to them.